Sitemap - 2020 - Longevity Marketcap Newsletter

Q&A: Post Your Questions Here

#019: Replacing Aging.

#018: A Tour of All Senolytics Companies.

#017: Longevity Biotech Investing According to Venture Capital.

#016: Every Single Longevity Therapy in Clinical Trial Today (PART 2).

#015: A Review of Every Single Longevity Therapy in Clinical Trial Today. (PART 1)

#014: How to Modulate Human Biology

#013: AgeX Therapeutics Deep Dive.

#012: Longevity ETFs are here. But are they any good?

#011: Bio Eats World?

#010: Frequency Therapeutics Deep Dive. Regenerative Medicine x Progenitor Cell Pathways

#009: What a VC Wants, What a VC Needs. VC Roundtable ARDD 2020.

#008: Longevity Investing Intel from ARDD 2020 Conference

#007: Hot or Not: Longevity Biotech Companies Edition

#006: Portfolio and UBX Failure Roundup

#005: Requiem for a UBX0101 Dream

#004: How to invest in longevity companies according to Juvenescence CEO Dr. Gregory Bailey

Thread: My entries this week. (Aug 6th, 2020)

#003: Are Billionaire Jim Mellon's suggested longevity stock portfolios any good?

Thread: What longevity biotech and other biotech stocks are you looking at right now? (July 29, 2020)

#002: Lessons from Billionaire Longevity Investor Jim Mellon

#001: Longevity Investing Market Pulse

Investing in the longevity biotechnology revolution

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts